NCI-H520 Luciferase Reporter Cell Line
1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
The NCI-H520 Luciferase cell line is transformed from NCI-H520 cell, expressing the firefly luciferase gene. The cell constitutively express Luciferase.
Product Code | NCI-H520 Luciferase Cell Line |
Species | Human |
Cat.No | ABC-RC113H |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Transfected Stable Cell Lines |
Size/Quantity | 1 vial |
Cell Type | Epithelial |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Lung |
Disease | Adenocarcinoma |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Reporter Stable Cell Line |
Host Cell | NCI-H520 Cell Line |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
For research use only
The NCI-H520 Luciferase Reporter Cell Line is designed for research on lung squamous cell carcinoma. It allows researchers to monitor gene expression and study cellular responses by utilizing the luciferase reporter system, which provides a convenient and sensitive method for detecting luminescent signals.
The recommended culture conditions include using RPMI 1640 medium supplemented with 10% Fetal Bovine Serum (FBS) and 1% penicillin-streptomycin. The cells should be cultured at 37°C in a 5% CO₂ atmosphere.
Upon receiving the cryovial, place it in a 37°C water bath to thaw quickly. After thawing, transfer the cells into a tube with 5 mL of complete medium, centrifuge at 200×g for 5-10 minutes, and discard the supernatant. Resuspend the cells in fresh medium, and incubate them in a 37°C CO₂ incubator.
When cells reach 80%-90% confluency, aspirate the medium, wash the cells with PBS, and treat them with 0.25% trypsin-EDTA to detach the cells. Neutralize the trypsin with complete medium, centrifuge the cells, and resuspend them in fresh medium. The recommended passage ratio is 1:2 to 1:4, with medium changes every 2 to 3 days.
The cell line undergoes stringent quality control, including tests for HIV-1, HBV, HCV, mycoplasma, fungi, yeast, and bacterial contamination, all of which must be negative. The viability of the cells is ensured to be over 90%, with a cell count of at least 1×10⁶ cells per vial.